ew share trade after-hour attribut market initi reaction
transcathet aortic valv replac tavr sale come shi consensu
expect tavr sale underli basi slow
sequenti reflect market share loss y/i intern manag
maintain tavr underli growth target expect growth
ramp thank low risk result expect late fda indic
expans new product maintain view tavr/tmtt opportun
price maintain underweight rate
gaug tavr ramp view manag tri temper expect
signific step-up tavr sale result data instead expect
ramp-up time note take time chang practic medicin
agre last point believ market expect may high ew
submit data fda believ suffici approv
 doesnt need sub-studi result worri may necessari
still expect late edward face addit competit
tavr us ou though guidanc assum global share stabil
tmtt better expect transcathet mitral tricuspid sale
lead manag increas confid abil hit target
accord manag sale reflect procedur trend
materi stock impact await pascal data
come week better assess competit product
addit takeaway call see kstew call note focus
expect ramp tavr sale publish via link
model chang rais ep reflect beat howev
maintain ep price target remain appli versu prior
pe multipl ep
ew quarterli annual ep usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
underweight believ sale growth like
slow edward face competit transcathet
aortic valv tavr expect limit leverag
edward invest transcathet mitral valv
tmvr/r opportun sale ep estim
street tmvr/r repres potenti
second act still risk like
upsid case may driven better-than-
expect tavr sale greater leverag
stronger uptak tmvr europ faster-
than-expect time tmvr/r product
downsid case may driven delay
inabl commerci tmvr/r technolog
slowdown tavr sale due market slowdown
and/or competit pressur fx rate
greater expens support tmvr/r
sale slightli street mainli driven higher critic
structur heart valv sale tavr expect reflect
underli growth tmtt sale underli sale
consist growth would full year rang
ep street/our estim well upper
end guidanc rang beat function higher gross
margin lower sg lower tax rate edward rais full year ep
guidanc rang guidanc bracket street
expect net/net noth chang view outlook stock
addit detail quarter
million except per share data chang sale constant currenc underli basi unless otherwis note
gross margin improv y/i benefit mostli foreign
exchang also product mix
critic sale structur heart streetaccount sa
consensu critic sale versu sa led surg
hemospher sale primarili structur heart sale versu
sa
tmtt sale estim
tavr sale estim reflect underli
sale growth reflect market share loss y/i intern
underli growth full year target
oper margin due higher sg spend y/i
ep guidanc rang rais though
less beat expens defer
sale underli basi underli growth divis
transcathet aortic structur heart critic
gross margin y/i benefit fx rate
sg sale y/i driven field personnel expens
partial off-set weaken euro dollar
 sale y/i edward continu invest clinic trial
transcathet structur heart program
oper margin y/i
adjust tax rate y/i includ benefit
stock-bas compens
adjust ep street/our estim
edward expect sale versu street pre-releas ep versu street pre-
edward continu expect total sale rang underli underli basi ew
continu expect transcathet aortic valv replac tavr growth surgic structur heart growth
critic growth though critic care full year sale dollar rang rais transcathet mitral tricuspid therapi
tmtt sale still expect line item guidanc rang remain unchang howev edward rais adjust ep
guidanc
actual million salesrptdunderlyingtranscathet aortic mitral tricuspid heart street divis estim streetaccount els refinitivyoy barclay edward lifesci corp
abbrevi incom statement million except per share data
incom statementnet oper inc inc barclay edward lifesci corp
kristen stewart cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
